This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Somavert® (pegvisomant) ​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

United Kingdom

  • Somavert (pegvisomant) 10 mg powder and solvent for solution for injection 
  • Somavert (pegvisomant) 15mg powder and solvent for solution for injection 
  • Somavert (pegvisomant) 20mg powder and solvent for solution for injection 
  • Somavert (pegvisomant) 25mg powder and solvent for solution for injection 
  • Somavert (pegvisomant) 30mg powder and solvent for solution for injection 

Somavert (pegvisomant) 10 mg powder and solvent for solution for injection 

Somavert (pegvisomant) 15mg powder and solvent for solution for injection 

Somavert (pegvisomant) 20mg powder and solvent for solution for injection 

Somavert (pegvisomant) 25mg powder and solvent for solution for injection 

Somavert (pegvisomant) 30mg powder and solvent for solution for injection 

PP-SOM-GBR-1383 January 2025